HIGHLIGHTS
- who: Benoit Busser and colleagues from the Biochemistry Pharmacology and Toxicology Department, Grenoble University Hospital, Grenoble, France have published the research: Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications, in the Journal: BioMed Research International of 11/08/2016
- future: There is a reason to believe that ctDNA will play the unhoped-for role of the currently missing gold-standard blood-based biomarker for the monitoring of melanoma in the near future.
SUMMARY
This minimally invasive method to access cancer-derived . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.